BioWorld

Sep. 1, 2006

View Archived Issues

Micromet Secures Funding In $25M Financing Facility

Ensuring ample cash reserves to support development of its cancer and inflammatory drug pipeline, Micromet Inc. gained access to up to $25 million through a committed equity financing facility. (BioWorld Today) Read More

Cerus Settles Class-Action Suit, Ends Headache For Management

Read More

Santarus: GERD Progress Could Lure Buyer To Table

Read More

Emergent Awarded NIAID Grants For Anthrax Agent

Read More

Holiday Notice

Read More

Other News To Note

Read More

Clinic Roundup

Read More

U.S. Patent Disclosures

Read More